CP
SHC icon

Castleview Partners’s Sotera Health SHC Stock Holding History

Castleview Partners’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+12,086
New +$190K 0.09% 205

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Castleview Partners's SHC Position: Q2 2026 in Review

Castleview Partners opened a new position in Sotera Health (SHC) in Q2 2026: 12,086 shares worth $215K. The stake represents 0.09% of the portfolio and ranks #205 among its holdings.

316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Castleview Partners held 12,086 shares of Sotera Health worth $215K as of Q2 2026.
  • Sotera Health was a new Castleview Partners position in Q2 2026.
  • Sotera Health made up 0.09% of Castleview Partners's portfolio in Q2 2026, its #205 holding.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.